Phagenesis

Manchester, United Kingdom · Founded 2007 · Privately Held (backing)

Developer of a medical device designed to provide treatment of acute dysphagia. Phagenesis is based in Manchester, United Kingdom and was founded in 2007. Its last reported valuation was $51.3 million in Aug 2025. It has raised $90 million.

Last reported valuation

$51.3M

Oct 2026

Priced at

—

Total raised

$90.0M

Last round

—

How much has Phagenesis raised?

$90.0Macross 0 recorded rounds

Free account

More of Phagenesis with a free account

·The complete investor list: 11 names
·Watch Phagenesis: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Phagenesis investors

11 investors are on record for Phagenesis, including MedTech Innovator, British Business Bank, Wellcome Trust and Northern Gritstone.

For fundraisers

Raising for a company like Phagenesis?

11 investors have backed Phagenesis.

See all 11 investors →

Frequently asked about Phagenesis

How much has Phagenesis raised?: Phagenesis has raised $90.0M in total across 0 recorded funding rounds.